brincidofovir 4 Tablet Pack

RxCUI: 2599540
RxNorm name: brincidofovir 4 Tablet Pack
Display name: brincidofovir 4 Tablet Pack
Full name: brincidofovir 4 Tablet Pack
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:53

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Tembexa	BRINCIDOFOVIR	Emergent BioDefense Operations Lansing LLC	209aa94b-c613-4880-ad89-41be83d12c0a	2025-07-01	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2599540

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
31d6fa29-791e-4988-8758-e7e4d5b6a352	{4 (brincidofovir 100 MG Oral Tablet) } Pack [GPCK] · brincidofovir 4 Tablet Pack [PSN] · brincidofovir 4 Tablet Pack [SY]	3	4	These highlights do not include all the information needed to use TEMBEXA ® safely and effectively. See full prescribing information for TEMBEXA. TEMBEXA (brincidofovir) tablets, for oral use TEMBEXA (brincidofovir) oral suspension Initial U.S. Approval: 1996	20220418
209aa94b-c613-4880-ad89-41be83d12c0a	{4 (brincidofovir 100 MG Oral Tablet) } Pack [GPCK] · brincidofovir 4 Tablet Pack [PSN] · brincidofovir 4 Tablet Pack [SY]	3	2	These highlights do not include all the information needed to use TEMBEXA ® safely and effectively. See full prescribing information for TEMBEXA . TEMBEXA (brincidofovir) tablets, for oral use TEMBEXA (brincidofovir) oral suspension Initial U.S. Approval: 1996	20250701